학술논문
Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors
Document Type
Article
Author
Sousa, B.B.; Cavaco, M.; Neves, V.; Labaõ-Almeida, C.; Coelho, A.R.; Bento, M.L.; Oliveira, B.L.; Castanho, M.A.R.B.; Joaõ, C.; Bernardes, G.J.L.; Carvalho, L.A.R.; de Almeida, C.R.; Barahona, A.F.; Lopes, R.; Martins-Logrado, A.; Krall, N.; Fior, R.; Lopes, R.M.R.M.; Neumeister, P.; Deutsch, A.; Vladimer, G.I.; Corzana, F.; Seixas, J.D.
Source
In: ACS Pharmacology and Translational Science . (ACS Pharmacology and Translational Science, 11 November 2022, 5(11):1156-1168)
Subject
Language
English
ISSN
25759108